This is the major research line of the group.
Along the realisation of a Transfer of Knowledge Industry Academia Partnership with AstraZeneca UK (Department of Drug Metabolism and Pharmacokinetics Alderley Park) and a European Reintegration Grant (Dr. H. Gika) the core of the bioanalysis group research is focused on global metabolite profiling using hyphenated techniques (LC-MS, GC-MS) and NMR.
We now run EmryoMetabolomics (GSRT, 2012-2015) and two Irakleitos grants (GSRT, 2010-2013) on arthritis and drug toxicity assessment.
The major scope of our research lays on the discovery of biomarkers of disease onset (diagnosis) and progression (prognostic markers), drug efficacy and drug toxicity.